BR112021026839A2 - Composições farmacêuticas para tratar e para prevenir uma doença infecciosa do vírus influenza - Google Patents

Composições farmacêuticas para tratar e para prevenir uma doença infecciosa do vírus influenza

Info

Publication number
BR112021026839A2
BR112021026839A2 BR112021026839A BR112021026839A BR112021026839A2 BR 112021026839 A2 BR112021026839 A2 BR 112021026839A2 BR 112021026839 A BR112021026839 A BR 112021026839A BR 112021026839 A BR112021026839 A BR 112021026839A BR 112021026839 A2 BR112021026839 A2 BR 112021026839A2
Authority
BR
Brazil
Prior art keywords
influenza virus
treating
preventing
infectious disease
pharmaceutical compositions
Prior art date
Application number
BR112021026839A
Other languages
English (en)
Portuguese (pt)
Inventor
syou OKIYAMA
Original Assignee
Aillis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aillis Inc filed Critical Aillis Inc
Publication of BR112021026839A2 publication Critical patent/BR112021026839A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/24—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the mouth, i.e. stomatoscopes, e.g. with tongue depressors; Instruments for opening or keeping open the mouth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/00147—Holding or positioning arrangements
    • A61B1/00148—Holding or positioning arrangements using anchoring means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
    • A61B1/05—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances characterised by the image sensor, e.g. camera, being in the distal end portion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0077—Devices for viewing the surface of the body, e.g. camera, magnifying lens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0088—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for oral or dental tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/02028—Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Measuring devices for evaluating the respiratory organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
    • A61B5/201—Assessing renal or kidney functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4866—Evaluating metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813—Specially adapted to be attached to a specific body part
    • A61B5/6814—Head
    • A61B5/682—Mouth, e.g., oral cavity; tongue; Lips; Teeth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/0002—Inspection of images, e.g. flaw detection
    • G06T7/0012—Biomedical image inspection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/20—Heterogeneous data integration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dentistry (AREA)
  • Optics & Photonics (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Physiology (AREA)
  • Theoretical Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Quality & Reliability (AREA)
  • General Physics & Mathematics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
BR112021026839A 2019-07-03 2020-06-30 Composições farmacêuticas para tratar e para prevenir uma doença infecciosa do vírus influenza BR112021026839A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019124750 2019-07-03
PCT/JP2020/025652 WO2021002355A1 (ja) 2019-07-03 2020-06-30 インフルエンザウイルス感染症を治療するための医薬組成物

Publications (1)

Publication Number Publication Date
BR112021026839A2 true BR112021026839A2 (pt) 2022-02-22

Family

ID=74101322

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021026839A BR112021026839A2 (pt) 2019-07-03 2020-06-30 Composições farmacêuticas para tratar e para prevenir uma doença infecciosa do vírus influenza

Country Status (9)

Country Link
US (2) US12245754B2 (https=)
EP (2) EP3995149A4 (https=)
JP (2) JPWO2021002355A1 (https=)
KR (1) KR20220034130A (https=)
CN (2) CN114340637A (https=)
BR (1) BR112021026839A2 (https=)
CA (1) CA3145200A1 (https=)
MX (1) MX2021016040A (https=)
WO (1) WO2021002355A1 (https=)

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01148233A (ja) * 1987-12-07 1989-06-09 Olympus Optical Co Ltd マウスピース
JP3510343B2 (ja) * 1994-08-23 2004-03-29 オリンパス株式会社 電子内視鏡
US6257238B1 (en) * 2000-05-25 2001-07-10 Nizam M. Meah Bite block for upper gastrointestinal endoscopy with tongue depressor
FR2824723B1 (fr) * 2001-05-15 2003-08-15 Univ Joseph Fourier Embout destine a un dispositif d'evaluation de la sensibilite du pharynx, dispositif le comportant et procede d'utilisation
US7807174B2 (en) 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
WO2005104926A1 (ja) * 2004-04-30 2005-11-10 J. Morita Manufacturing Corporation 生体観察機器、口腔内撮影装置及び医療用診療器具
WO2009023356A2 (en) * 2007-05-25 2009-02-19 Omega-Biopharma (H.K.) Limited Materials and methods for treating influenza infections
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
JP5145587B2 (ja) * 2007-12-27 2013-02-20 晃一 角田 口腔挿入具および口腔咽頭鏡装置
CN101787008A (zh) * 2009-01-23 2010-07-28 中国科学院上海药物研究所 N-乙酰神经氨酸类化合物、其药物组合物及其制备方法和用途
US10022449B2 (en) * 2009-12-22 2018-07-17 Marinomed Biotechnologie Gmbh Synergistic antiviral composition and use thereof
EP2868096B1 (en) * 2012-06-27 2020-08-05 Zipline Health, Inc. Devices, methods and systems for acquiring medical diagnostic information and provision of telehealth services
US9555094B2 (en) 2012-07-23 2017-01-31 The Institute Of Biological Resources Isolated nucleic acid for the production of a vaccine against virus
HK1209646A1 (en) 2012-12-28 2016-04-08 日本国立感染症研究所 Nasal influenza vaccine composition
MX387277B (es) 2013-03-14 2025-03-12 Contrafect Corp Composiciones basadas en anticuerpos neutralizantes suministrados intranasalmente para eficacia terapéutica aumentada.
US10632010B2 (en) * 2014-04-01 2020-04-28 Oventus Medical Limited Breathing assist device
EP3294106B1 (en) * 2015-05-12 2020-08-26 Zipline Health, Inc. Devices for acquiring medical diagnostic information and provision of telehealth services
CA2986363C (en) * 2015-05-19 2021-10-26 Tyto Care Ltd. Systems and methods for throat imaging
JP6837258B2 (ja) * 2016-11-18 2021-03-03 国立大学法人鳥取大学 喉頭鏡及び喉頭鏡用ブレード
JP6844088B2 (ja) * 2017-01-25 2021-03-17 株式会社メドレー 医療情報提供方法、医療情報提供装置、及びプログラム
US11104689B2 (en) * 2017-09-18 2021-08-31 Sunshine Lake Pharma Co., Ltd. Influenza virus replication inhibitor and use thereof
JP7267608B2 (ja) 2017-12-28 2023-05-02 アイリス株式会社 口内撮影装置、医療装置及びプログラム
CN109504721B (zh) * 2018-12-26 2021-07-09 杭州科巢生物科技有限公司 一种抗流感药物的合成方法

Also Published As

Publication number Publication date
US20250176815A1 (en) 2025-06-05
EP4599758A2 (en) 2025-08-13
JPWO2021002355A1 (https=) 2021-01-07
EP3995149A4 (en) 2023-07-19
CN114340637A (zh) 2022-04-12
KR20220034130A (ko) 2022-03-17
CN119679357A (zh) 2025-03-25
CA3145200A1 (en) 2021-01-07
US12245754B2 (en) 2025-03-11
EP3995149A1 (en) 2022-05-11
EP4599758A3 (en) 2025-11-05
JP2025084816A (ja) 2025-06-03
US20220361741A1 (en) 2022-11-17
WO2021002355A1 (ja) 2021-01-07
MX2021016040A (es) 2022-03-11

Similar Documents

Publication Publication Date Title
CO2024006742A2 (es) Compuestos terapéuticos para la infección por el virus del vih
BR112021021637A2 (pt) Vacina de subunidade para tratamento ou prevenção de uma infecção do trato respiratório
EA201690069A1 (ru) Применение высоких доз придопидина для лечения болезни хантингтона
BR112012030641A2 (pt) métodos e composições para terapia farmacêutica oral
MX2022007908A (es) Combinacion farmaceutica de un oligonucleotido terapeutico que actua sobre hbv y un agonista de tlr7 para el tratamiento de hbv.
ES2570401T3 (es) Métodos de tratamiento usando dosis únicas de oritavancina
AR108829A1 (es) Vacuna contra virus de bronquitis infecciosa
CO2023003242A2 (es) Vacuna contra el coronavirus y procedimiento para la preparación de la misma
WO2020076760A3 (en) Sphingoid compounds for use in the prophylaxis and/or therapy of a viral infection
AR093185A1 (es) Virus prrs (sindrome reproductivo y respiratorio porcino) que induce al interferon tipo i en celulas susceptibles
CL2021003312A1 (es) Composición que comprende pridopidina y un análogo de la misma para el tratamiento de la enfermedad de huntington y síntomas de la misma.
MX2019015927A (es) Composiciones para administración de fármacos y métodos de uso de las mismas.
MX2021010834A (es) Compuesto y metodo para la prevencion de transmision del virus de influenza.
BR112022010798A2 (pt) Derivado de metileno-naftaleno-éter de fenilisoxazolila, seu uso e composição farmacêutica compreendendo o mesmo
EA201592040A1 (ru) Иммуногенная композиция для применения в терапии
MX2015013115A (es) Nuevos regimenes de dosificacion de celgosivir para el tratamiento de dengue.
CL2018003682A1 (es) Composición farmacéutica oral, que comprende un agente farmacéuticamente activo, al menos un polímero catiónico bioadhesivo y al menos dos polímeros aniónicos.
BR112016012435A8 (pt) vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2
MX2023013226A (es) Métodos para tratar, mejorar o prevenir infecciones mediante un tratamiento combinado de farmacos y vacunación.
CO2022016537A2 (es) Vacuna inactivada para sars-cov-2 y preparación de la misma
BR112018072177A2 (pt) composição farmacêutica, recipiente, e, métodos para tratar e prevenir congestão nasal, infecções virais do trato respiratório e/ou inflamação da garganta
BR112021026839A2 (pt) Composições farmacêuticas para tratar e para prevenir uma doença infecciosa do vírus influenza
CO2020000292A2 (es) Preparación medicinal combinada para tratar infecciones virales
GEAP202215586A (en) Therapy of high-risk human papillomavirus infections
BR112021006388A2 (pt) composto, composição farmacêutica, uso de um composto, e, método para tratamento de uma infecção viral em um mamífero